← Back to headlines
Novo Nordisk Under Scrutiny in Estonia for Suspected Drug Advertising
Novo Nordisk, the manufacturer of Ozempic, is facing suspicions in Estonia over a campaign that directs people to private clinics discussing weight-loss drugs, which authorities believe might constitute illegal advertising for prescription medications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
